Oragenics
OGEN
18 hedge funds and large institutions have $402K invested in Oragenics in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 8 closing their positions.
602% more capital invested
Capital invested by funds: $57.2K → $402K (+$344K)
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
6% more funds holding
Funds holding: 17 → 18 (+1)
0.45% more ownership
Funds ownership: 0.04% → 0.49% (+0.45%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$358K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$78.8K |
| 3 |
Morgan Stanley
New York
|
+$59.6K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$12.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$8.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$17.8K |
| 2 |
GWM
GSB Wealth Management
Guilford,
Connecticut
|
-$6.5K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$5.27K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$5.22K |
| 5 |
Two Sigma Investments
New York
|
-$3.83K |
OGEN Hedge Fund Activity: Q2 2025 in Review
18 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2025, worth a combined $402K — up 602% from $57.2K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new OGEN positions and 8 closed out — a net gain of 1 holder — while 7 added to existing stakes and 1 trimmed.
The largest buyer was Clear Street, opening a new position worth an estimated $358K. The largest seller was Geode Capital Management, exiting entirely with an estimated $17.8K sold.
- 18 institutional investors held Oragenics (OGEN) as of Q2 2025, up from 17 in Q1 2025.
- Funds reported $402K of Oragenics stock for Q2 2025, up 602% quarter-over-quarter.
- 9 funds opened new Oragenics positions in Q2 2025 and 8 closed out, a net change of +1 holder.
- The largest Oragenics buyer in Q2 2025 was Clear Street, an estimated $358K added.
- The largest Oragenics seller in Q2 2025 was Geode Capital Management, an estimated $17.8K sold.
Based on aggregated 13F filings for Q2 2025.